Wikidata

(Q65382380)

English

An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)

clinical trial

In more languages

Statements

short name
RHAPSODY (English)
0 references
title
Review of Safety and Efficacy With Adalimumab in Patients With Active Ankylosing Spondylitis - An Open-Label Study to Evaluate the Response to Adalimumab in Patients Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) (English)
0 references
country
Austria
0 references
Belgium
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Republic of Ireland
0 references
Italy
0 references
Netherlands
0 references
Norway
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
United Kingdom
0 references
start time
February 2006
0 references
number of participants
1,250
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65382380&oldid=1858379342"